Safety, Reactogenicity and Immunogenicity of Two Quadrivalent Seasonal Influenza Vaccines (Fluzone(R) or Flublok(R)) With or Without One of Two Adjuvants (AF03 or Advax-CpG55.2) in Healthy Adults

Conditions:   Influenza;   Influenza Immunisation Interventions:   Biological: Advax-CpG55.2;   Drug: AF03;   Biological: Influenza Virus Quadrivalent Inactivated Vaccine;   Biological: Quadrivalent Recombinant Seasonal Influenza Vaccine Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials